Confounders of excessive brain volume loss in schizophrenia

被引:56
|
作者
Van Haren, N. E. [1 ]
Cahn, W. [1 ]
Pol, H. E. Hulshoff [1 ]
Kahn, R. S. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands
关键词
Schizophrenia; MRI; Brain volumes; Longitudinal; Antipsychotic medication; Cannabis; Outcome; CAUDATE NUCLEI VOLUMES; MATTER DENSITY CHANGES; 1ST EPISODE PSYCHOSIS; FOLLOW-UP; 1ST-EPISODE SCHIZOPHRENIA; CEREBROSPINAL-FLUID; VENTRICULAR ENLARGEMENT; PROGRESSIVE DECREASE; ONSET SCHIZOPHRENIA; HIPPOCAMPAL VOLUME;
D O I
10.1016/j.neubiorev.2012.09.006
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
There is convincing evidence that schizophrenia is characterised by progressive brain volume changes during the course of the illness. In a large longitudinal study it was shown that different age-related trajectories of brain tissue loss are present in patients compared to healthy subjects, suggesting that brain maturation that occurs in the third and fourth decade of life is abnormal in schizophrenia. However, studies show that medication intake and cannabis use are important confounding factors when interpreting brain volume (change) abnormalities. Indeed, continues use of cannabis, but not cigarette smoking, is associated to a more pronounced loss of grey matter in the anterior cingulated and the prefrontal cortex. Atypical antipsychotics have been found to be related to smaller decreases in tissue loss. Moreover, independent of antipsychotic medication intake, the brain volume abnormalities appear associated to the outcome of the illness. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2418 / 2423
页数:6
相关论文
共 50 条
  • [41] Brain volume in chronic ketamine users - relationship to sub-threshold psychotic symptoms and relevance to schizophrenia
    Chesters, Robert A.
    Pepper, Fiona
    Morgan, Celia
    Cooper, Jonathan D.
    Howes, Oliver D.
    Vernon, Anthony C.
    Stone, James M.
    PSYCHOPHARMACOLOGY, 2022, 239 (11) : 3421 - 3429
  • [42] Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia
    Robert A. Chesters
    Fiona Pepper
    Celia Morgan
    Jonathan D. Cooper
    Oliver D. Howes
    Anthony C. Vernon
    James M. Stone
    Psychopharmacology, 2022, 239 : 3421 - 3429
  • [43] The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients
    Liu, Jingyu
    Julnes, Peter Siyahhan
    Chen, Jiayu
    Ehrlich, Stefan
    Walton, Esther
    Calhoun, Vince D.
    SCHIZOPHRENIA RESEARCH, 2015, 169 (1-3) : 447 - 452
  • [44] Regional Gray Matter Volume in Monozygotic Twins Concordant and Discordant for Schizophrenia
    Borgwardt, Stefan J.
    Picchioni, Marco M.
    Ettinger, Ulrich
    Toulopoulou, Timothea
    Murray, Robin
    McGuire, Philip K.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (10) : 956 - 964
  • [45] What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia
    Pol, Hilleke E. Hulshoff
    Kahn, Rene S.
    SCHIZOPHRENIA BULLETIN, 2008, 34 (02) : 354 - 366
  • [46] Longitudinal changes in hippocampal volume in the Edinburgh High Risk Study of Schizophrenia
    Bois, C.
    Levita, L.
    Rippc, I.
    Owens, D. C. G.
    Johnstone, E. C.
    Whalley, H. C.
    Lawrie, S. M.
    SCHIZOPHRENIA RESEARCH, 2016, 173 (03) : 146 - 151
  • [47] Subcortical Volume Changes in Schizophrenia and Bipolar Disorder: A Quantitative MRI Study
    Demir, Mehmet
    Findikli, Ebru
    Tuncel, Deniz
    Atay, Emre
    Baykara, Murat
    Acer, Niyazi
    Doganer, Adem
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2024, 42 (02): : 503 - 509
  • [48] Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
    Fusar-Poli, P.
    Smieskova, R.
    Kempton, M. J.
    Ho, B. C.
    Andreasen, N. C.
    Borgwardt, S.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (08) : 1680 - 1691
  • [49] Pituitary volume in schizophrenia spectrum disorders
    Romo-Nava, F.
    Hoogenboom, W. S.
    Pelavin, P. E.
    Alvarado, J. L.
    Bobrow, H.
    MacMaster, F. P.
    Keshavan, M.
    McCarley, R. W.
    Shenton, M. E.
    SCHIZOPHRENIA RESEARCH, 2013, 146 (1-3) : 301 - 307
  • [50] Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
    De Stefano, Nicola
    Silva, Diego G.
    Barnett, Michael H.
    CNS DRUGS, 2017, 31 (04) : 289 - 305